New York Times Vital Signs By NICHOLAS BAKALAR Published: November 14, 2011 The two vaccines against human papillomavirus together target the four types of HPV that cause a large majority of cervical and anal cancers. But there are more than a dozen other cancer-causing HPV types, and scientists have been concerned that as more people […]
Targeting HPV 16/18 shows promise in cancer risk reduction
Infectious Disease News Posted August 26, 2011 New vaccine provides ‘strong protection’ for anal cancer, and researchers discover that separate screening for HPV 16/18 may represent a more effective screening strategy. Results from two recently released studies show that researchers are seeing progress in preventing HPV-related anal cancer and in screening for HPV-related cervical cancer. […]
SaneVax Pregunta a la FDA sobre Gardasil ® ¿Que están haciendo?
BWN Argentina – Ultimas Noticias Argentina April 15, 2010 Médicos de todo el mundo y el publico aplauden la reciente decisión de la FDA de no ampliar el uso de Gardasil para mujeres mayores de 26 años de edad. Ahora quieren saber cuándo la FDA admitirá que la aprobación original para niñas fue un error. […]
November 16-17, 2010: Vaccines and Related Biological Products Advisory Committee Meeting Summary Minutes
Food and Drug Administration Center for Biologics Evaluation and Review SUMMARY MINUTES VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE November 16 – 17, 2010 Silver Spring Hilton, Silver Spring, MD The Chair, Dr. Jack Stapleton, called the Meeting of the Vaccines and Related Biological Products Advisory Committee to order at 9:00 a.m. EST on November […]
HPV Affects Half Of U.S. Men
The Huffington Post Dr. Jon LaPook Medical correspondent for the CBS Evening News with Katie Couric Posted: March 1, 2011 07:02 AM A study out yesterday in The Lancet by Moffitt Cancer Center researcher Anna Giuliano, Ph.D., and her colleagues finds that 50 percent of men ages 18 to 70 in Brazil, Mexico, and the […]
- 1
- 2
- 3
- …
- 10
- Next Page »
